Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-11

Clinical Trial Update: Comparative Efficacy of Resveratrol 1 % Gel and Trichloroacetic Acid 20% in Treatment of Melasma: A Split-face Study [NA]

View source ↗

Summary

This entry describes a split-face clinical trial comparing Resveratrol 1% Gel with Trichloroacetic Acid 20% for treating Melasma, sponsored by Assiut University…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Resveratrol 1% Gel (Resveratrol 1% gel)
  • Trichloroacetic Acid 20% (Trichloroacetic acid 20%)

Snippet

Sponsor: Assiut University | Conditions: Melasma | NA | Status: NOT_YET_RECRUITING